Evidence map›Paper›PMID 40751859›Full record

ArticleEJNMMI research2025

Total-body

Jie Xiao, Shuguang Chen, Xiaoguang Hou, Haojun Yu, Siwei Liu, Taoying Gu, Guobing Liu, Qi Ge, Jingyi Wang, Hongcheng Shi

Abstract read
In one paragraph

Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jie XiaoDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd, Shanghai, China.
Shuguang ChenDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd, Shanghai, China.
Xiaoguang HouDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd, Shanghai, China.
Haojun YuDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd, Shanghai, China.
Siwei LiuDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd, Shanghai, China.
Taoying GuDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd, Shanghai, China.
Guobing LiuDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd, Shanghai, China.
Qi GeCentral Research Institute, United Imaging Healthcare Co., Ltd, Shanghai, China.
Jingyi WangCentral Research Institute, United Imaging Healthcare Co., Ltd, Shanghai, China.
Hongcheng ShiDepartment of Nuclear Medicine, Zhongshan Hospital, 180 Fenglin Rd, Shanghai, China. shi.hongcheng@zs-hospital.sh.cn.

Funding

Program of Shanghai Municipal Commission of Economy and Informatization 23SHS01200the Chinese National Key Clinical Specialty Program YWP2022-007the Key Program of Ministry of Industry and Information Technology of China CEIEC-2022-ZM02-0219the National Key Research and Development Program of China 2022YFC2406902
6 · The paper itself

Abstract

backgroundThe study aims to maximize clinical scan efficiency for Total-body (TB)

resultsThis prospective study include two parts. The first part involved simulation experiments using theoretical models to maximize patient throughput and/or minimizing radiotracer activity across four clinical scanning scenarios: fixed working time, predetermined radiotracer activity, integration of various injection activity regimens for a fixed number of patients, and incorporation of dynamic scans into routine static scans within a fixed working time. The optimal scan strategies for these scenarios were then proposed. The second part validated the estimated throughput results through high-throughput tests performed in the real clinical settings with an fixed working time of 8 h. Under a fixed working time of 8 h, the theoretical patient throughput for full-activity, half-activity, 1/3-activity, and 1/10-activity injection regimens was 60, 48, 43, 30 patients, respectively. The corresponding real clinical throughput achieved was 60, 49, 48, 28 patients. For a total

conclusionsOptimized scan strategies for typical clinical scenarios of TB

Indexed as

18F-FDGScanning efficiencyScan strategyThroughputTotal-body PET/CT

Identifiers

PMID40751859
PMCPMC12317942

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.